Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Organovo Holdings (ONVO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 126,320
  • Shares Outstanding, K 115,890
  • Annual Sales, $ 4,600 K
  • Annual Income, $ -34,800 K
  • 36-Month Beta 2.51
  • Price/Sales 27.69
  • Price/Cash Flow N/A
  • Price/Book 3.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.08
  • Number of Estimates 2
  • High Estimate -0.07
  • Low Estimate -0.08
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.99 +7.07%
on 10/31/18
1.27 -16.54%
on 11/08/18
-0.04 (-3.64%)
since 10/16/18
3-Month
0.99 +7.07%
on 10/31/18
1.34 -20.90%
on 08/29/18
-0.10 (-8.62%)
since 08/16/18
52-Week
0.91 +16.48%
on 04/04/18
2.09 -49.28%
on 05/23/18
-0.39 (-26.90%)
since 11/16/17

Most Recent Stories

More News
Organovo (ONVO) Reports Q2 Loss, Tops Revenue Estimates

Organovo (ONVO) delivered earnings and revenue surprises of 37.50% and 4.43%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

ONVO : 1.06 (-2.75%)
Organovo: Fiscal 2Q Earnings Snapshot

SAN DIEGO (AP) _ Organovo Holdings Inc. (ONVO) on Thursday reported a loss of $5.8 million in its fiscal second quarter.

ONVO : 1.06 (-2.75%)
Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Second-Quarter 2019 Results

Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo"), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and pediatric liver diseases,...

ONVO : 1.06 (-2.75%)
Organovo Announces Release Date for Fiscal Second-Quarter 2019 Financial Results

Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo") will host a conference call on Thursday, November 8, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal second-quarter 2019 operating...

ONVO : 1.06 (-2.75%)
Report: Exploring Fundamental Drivers Behind Shenandoah Telecommunications, Nova Measuring Instruments, FRP, National Fuel Gas, Organovo, and Sierra Wireless -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Shenandoah Telecommunications...

NVMI : 23.51 (-0.38%)
FRPH : 50.17 (+3.44%)
SHEN : 47.87 (+1.57%)
SWIR : 16.43 (+0.06%)
ONVO : 1.06 (-2.75%)
NFG : 53.08 (+1.53%)
Organovo to Present at 2018 Cell & Gene Meeting on the Mesa

Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo"), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and pediatric liver diseases,...

ONVO : 1.06 (-2.75%)
Recent Analysis Shows Ellie Mae, Organovo, Calithera Biosciences, Whirlpool, Marathon Oil, and Infinera Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ellie Mae, Inc. (NYSE:ELLI),...

WHR : 117.10 (+3.38%)
ELLI : 67.67 (+1.68%)
MRO : 17.19 (+0.23%)
CALA : 5.17 (+0.39%)
ONVO : 1.06 (-2.75%)
INFN : 4.90 (-2.39%)
Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo" or the "Company") announced the grant of inducement awards on August 14, 2018 to Dr. Steven G. Hughes, its new chief medical officer. The inducement awards...

ONVO : 1.06 (-2.75%)
Organovo (ONVO) Reports Q1 Loss, Misses Revenue Estimates

Organovo (ONVO) delivered earnings and revenue surprises of 0.00% and -40.66%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

ONVO : 1.06 (-2.75%)
Organovo: Fiscal 1Q Earnings Snapshot

SAN DIEGO (AP) _ Organovo Holdings Inc. (ONVO) on Thursday reported a loss of $7.4 million in its fiscal first quarter.

ONVO : 1.06 (-2.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade ONVO with:

Business Summary

Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings,...

See More

Key Turning Points

2nd Resistance Point 1.15
1st Resistance Point 1.10
Last Price 1.06
1st Support Level 1.02
2nd Support Level 0.99

See More

52-Week High 2.09
Fibonacci 61.8% 1.64
Fibonacci 50% 1.50
Fibonacci 38.2% 1.36
Last Price 1.06
52-Week Low 0.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar